Literature DB >> 22142343

Why are we still using hydrochlorothiazide?

Clive Rosendorff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22142343      PMCID： PMC8108869          DOI： 10.1111/j.1751-7176.2011.00566.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  22 in total

1.  Chlorthalidone: don't call it "thiazide-like" anymore.

Authors:  Theodore W Kurtz
Journal:  Hypertension       Date:  2010-07-12       Impact factor: 10.190

2.  Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population.

Authors:  Tonje A Aksnes; Sverre E Kjeldsen; Morten Rostrup; Per Omvik; Tsushung A Hua; Stevo Julius
Journal:  Hypertension       Date:  2007-08-06       Impact factor: 10.190

3.  Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

Authors:  Michael E Ernst; Barry L Carter; Chris J Goerdt; Jennifer J G Steffensmeier; Beth Bryles Phillips; M Bridget Zimmerman; George R Bergus
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

4.  Chlorthalidone versus hydrochlorothiazide as the preferred diuretic: is there a verdict yet?

Authors:  John M Flack; Domenic A Sica; Shawna Nesbitt
Journal:  Hypertension       Date:  2011-03-07       Impact factor: 10.190

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.

Authors: 
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

7.  Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium.

Authors:  Michael E Ernst; Barry L Carter; Shimin Zheng; Richard H Grimm
Journal:  Am J Hypertens       Date:  2010-01-28       Impact factor: 2.689

8.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors:  Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Adverse prognostic significance of new diabetes in treated hypertensive subjects.

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Fabio Angeli; Claudia Borgioni; Roberto Gattobigio; Lucia Filippucci; Silvia Norgiolini; Costanza Bracco; Carlo Porcellati
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190
View more
  7 in total

1.  Hypertension: is it time to replace drugs with nutrition and nutraceuticals?

Authors:  Walter Alexander
Journal:  P T       Date:  2014-04

Review 2.  Type 2 Diabetes and Thiazide Diuretics.

Authors:  André J Scheen
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

3.  Patterns of nonadherence to antihypertensive therapy in primary care.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-26       Impact factor: 3.738

4.  Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR.

Authors:  Dénes Páll; Ildikó Szántó; Zoltán Szabó
Journal:  Clin Drug Investig       Date:  2014-10       Impact factor: 2.859

5.  Guidelines for use of diuretics: a view from a member of JNC 7.

Authors:  Barry L Carter
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04-11       Impact factor: 3.738

6.  Treatment of hypertension in CKD patients with azilsartan/chlorthalidone vs olmesartan/hydrochlorothiazide.

Authors:  Walter M van der Merwe
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-04       Impact factor: 3.738

7.  Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients.

Authors:  Sonal Singh; Caitrin W McDonough; Yan Gong; Wael A Alghamdi; Meghan J Arwood; Salma A Bargal; Leanne Dumeny; Wen-Yi Li; Mai Mehanna; Bradley Stockard; Guang Yang; Felipe A de Oliveira; Natalie C Fredette; Mohamed H Shahin; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; John G Gums; Stephen T Turner; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  J Am Heart Assoc       Date:  2018-03-09       Impact factor: 5.501
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.